Low-dose intradermal administration of recombinant hepatitis B vaccine in children: 5-year follow-up study

By Kurugol Z.   Erensoy S.   Aksit S.   Egemen A.   Bilgic A.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3936-3939

Elsevier

Access to resources Recommend Favorite

Intramuscular versus intradermal administration of anti-hepatitis B vaccine in non-cirrhotic hepatitis C patients

By Arbizu E.A.   Marugan R.B.   Grijalba J.Y.   Serrano P.L.   Grande L.G.   Del Campo Terron S.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2747-2750

Elsevier

Access to resources Recommend Favorite

Low-dose intramuscular revaccination against hepatitis B

By Ramon J.M.   Bou R.   Oromi J.  

Vaccine, Vol. 14, Iss. 17, 1996-12 ,pp. : 1647-1650

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age

By The Kaiser-UCLA Vaccine Study Group   Greenberg D.P.   Vadheim C.M.   Marcy S.M.   Partridge S.   Jing J.   Chung-Yin C.   Greene T.   Margolis H.S.   Ward J.I.  

Vaccine, Vol. 14, Iss. 8, 1996-06 ,pp. : 811-816

Elsevier

Access to resources Recommend Favorite

Hepatitis A vaccine: immunogenicity following administration of a delayed immunization schedule in infants, children and adults

By Williams J.L.   Bruden D.A.   Cagle H.H.   McMahon B.J.   Negus S.E.   Christensen C.J.   Snowball M.M.   Bulkow L.R.   Fox-Leyva L.K.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3208-3211

Elsevier

Access to resources Recommend Favorite